The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.
Aridis Pharmaceuticals - San Jose, Calif., 2 million shares, priced $13-$15, managed by Cantor Fitzgerald/Maxim Group LLC. Proposed Nasdaq symbol ARDS. Business: Developing immunotherapies for antibiotic-resistant infections.